₉Herbert Tilg

Summary for 2004 [at-glance overview of Herbert Tilg work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Herbert Tilg. According to available data, in 2004 Herbert Tilg published at least 9 articles. This work was completed in collaboration with several authors including Kaser, Arthur and Enrich, Barbara. Many other authors have collaborated with Herbert Tilg as well. There is no information about the funding or the grants awarded to support this work.

Herbert Tilg has rank 51 when compared to all other authors using the keyword Colitis, Ulcerative. Analysis of the article abstracts and the titles suggests that Herbert Tilg professional interests are focused around "inflammatory bowel disease", "human inflammatory bowel" and "interleukin-1 receptor antagonist". These might also be referred to as "dendritic cells", "bowel disease" or "inflammatory bowel". Statistical analysis shows that Herbert Tilg's writing is likely to contains terms "cells", "il-1ra", "expression", "disease", "human" and "ccl20".

Unfortunately, there is not enough information to establish Herbert Tilg affiliation. Luckily, one email address is on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Herbert Tilg]

Do you know Herbert Tilg who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Herbert Tilg]

₄₁Tilg, H

Year 2004 Charts [Herbert Tilg frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Herbert Tilg publication and funding history for the range of years]

Emails (1) [email addresses extracted from Herbert Tilg affiliations]

hidden to prevent spam, click here to reveal

Herbert Tilg Coauthors (44) [all coauthors with the number of joint publications]

explore visually

6

₁₂Kaser, Arthur

3

₃Enrich, Barbara

2

₁₉Wiedermann, Christian J

2

2

2

2

2

₂Moschen, Alexander R

1

1

1

1

1

1

1

1

1

1

1

1

1

1

₆Dunzendorfer, Stefan

1

₆Zatloukal, Kurt

1

₅Avila, Matias A

1

₅García-Trevijano, Elena R

1

1

1

1

1

₄Fuchsbichler, Andrea

1

₄Holzmann, Sandra

1

₃Brandacher, Gerald

1

₃Kirchgatterer, Andreas

1

₃Marschall, Hanns-Ulrich

1

₃Mookerjee, Rajeshwar P

1

1

1

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (8) [condensed summary of the Herbert Tilg affiliations, the leading number and the color conveys importance]

₁Department of Gastroenterology and Hepatology, Medical University of Innsbruck, Innsbruck, Austria.
₁Department of Medicine, Division of Gastroenterology and Hepatology, University Hospital Innsbruck, Internal Medicine, Innsbruck, Austria.
₁Clinical Division of General Internal Medicine, Clinical Department of Internal Medicine, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria.
₁Department of Internal Medicine, Karl-Franzens University Graz, Austria.
₁Deparment of Medicine, Medical University, Graz, Austria.
₁Departmetn of Medicine, Division of Gastroenterology and Hepatology, University Hospital Innsbruck, Austria.
₁Department of Medicine, University Hospital Innsbruck, Anichstr 35, 6020 Innsbruck, Austria.
₁Division of Gastroenterology and Hepatology, University Hospital Innsbruck, Innsbruck, Austria.

Key Opinion Leader In [Herbert Tilg is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₅₁Colitis, Ulcerative | ₇₂Crohn Disease | ₂₄₅Antibodies, Monoclonal

Keywords (32) [keywords assigned to Herbert Tilg articles by PubMed, the leading number and the color conveys importance]

₈Humans | ₄Male | ₃Crohn Disease | ₃Colitis, Ulcerative | ₃Animals | ₃Adult | ₃Female | ₃Antibodies, Monoclonal | ₂Cytokines | ₂Tumor Necrosis Factor-alpha | ₂RNA, Messenger | ₂Gastrointestinal Agents | ₂Mice | ₂Sialoglycoproteins | ₂Dose-Response Relationship, Drug | ₂Leukocytes, Mononuclear | ₂Interleukin 1 Receptor Antagonist Protein | ₂Gene Expression Regulation | ₂Dendritic Cells | ₂Lymphocyte Activation | ₂Middle Aged | ₂Anti-Inflammatory Agents | ₁Adiponectin | ₁Base Sequence | ₁Follow-Up Studies | ₁Bile Acids and Salts | ₁Bile Duct Diseases | ₁Questionnaires | ₁Epithelium | ₁Cell Differentiation | ₁Th2 Cells | ₁Hepatocyte Growth Factor

Herbert Tilg Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Herbert Tilg might be a good expert witness on these terms]

₁₈cells | ₁₃il-1ra | ₁₃expression | ₁₂disease | ₁₁human | ₁₀ccl20 | ₁₀anti-inflammatory | ₁₀inflammatory | ₁₀il-18 | ₁₀type | ₁₀hgf | ₉ibd | ₉dc2s | ₈cytokines | ₈response | ₈protein | ₈increased | ₈infliximab | ₈dendritic | ₇bowel | ₇effects | ₇mrna | ₇th1 | ₆adiponectin | ₅cd | ₅role | ₅might | ₅cytokine | ₅crohn | ₅synthesis | ₄colitis | ₄functions
₈dendritic cells | ₆bowel disease | ₆inflammatory bowel | ₆type ifns | ₅crohn disease | ₄human inflammatory | ₄effect il-1ra | ₄anti-inflammatory effects | ₄growth factor | ₃increased expression | ₃il-1ra mrna | ₃protein synthesis | ₃il-10 il-1ra | ₃mrna protein | ₃mrna expression | ₃inflammatory disorders | ₃bile duct | ₃receptor antagonist | ₃hepatocyte growth | ₃interleukin-1 receptor | ₃liver failure | ₃colonic biopsies | ₃indoleamine 3-dioxygenase | ₂exerts anti-inflammatory | ₂finally causing | ₂factor induction | ₂study long-term | ₂th1 response | ₂ccl20 ccr6 | ₂type interferons | ₂allogeneic naive | ₂disease cd
₆inflammatory bowel disease | ₄human inflammatory bowel | ₃interleukin-1 receptor antagonist | ₃hepatocyte growth factor | ₂bowel disease ibd | ₂effect il-1ra mrna | ₂effects hepatocyte growth | ₂experience crohn disease | ₂anti-inflammatory effects hepatocyte | ₂therapeutic role th2-regulated | ₂growth factor induction | ₂crohn disease nationwide | ₂ccl20 human inflammatory | ₂disease nationwide cooperative | ₂adiponectin induces anti-inflammatory | ₂atrophy death bile | ₂increased expression ccl20 | ₂lymphocytes dendritic cells | ₂role th2-regulated inflammatory | ₂death bile duct | ₂austrian infliximab experience | ₂cytokines il-10 il-1ra | ₂exerts anti-inflammatory effects | ₂induction interleukin-1 receptor | ₂cooperative study long-term | ₂bile duct epithelial | ₂study long-term follow-up | ₂induces anti-inflammatory cytokines | ₂nationwide cooperative study | ₂il-10 il-1ra human | ₂interferons therapeutic role | ₂infliximab experience crohn

Reader's Comments (0) [comments posted by readers of Herbert Tilg profile]